Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deoxycytidine kinase (DCK) is a crucial enzyme in the nucleoside salvage pathway, catalyzing the phosphorylation of deoxycytidine, deoxyadenosine, and deoxyguanosine. It plays a vital role in activating nucleoside analog prodrugs used as antiviral and chemotherapeutic agents. DCK is essential for maintaining deoxynucleotide triphosphate pools needed for DNA replication and repair, particularly in tissues with high lymphocyte turnover like the thymus and bone marrow. Its subcellular location is primarily within the cell nucleus.
Phosphorylation of deoxyribonucleosides and nucleoside analogs to their monophosphate forms, activating them for incorporation into DNA or RNA and inhibiting DNA/RNA synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxycytidine Kinase (DCK).